Keyword : chemotherapy
Clinical guidelines for diagnostic and treatment of patients with gastric and duodenum neuroendocrine tumorsAuthors: Zubarev M.H. Kolesnik O.O. Lukashenko A.V. Ostapenko U.V.... №4(28) 2017
Review of IV version of Japanese gastric cancer treatment guidelinesAuthors: Lukashenko A.V. Boiko A.V. Rozumeyko I.V. Koshubarova M.V. №3(27) 2017
Brentuхіmab vedotin in the treatment of Hodgkin’s lymphomaAuthors: Kryachok I. Titorenko I.B. №2(26) 2017
Toxic hepatitis in patients with lymphoproliferative diseasesAuthors: Kryachok I. Pastushenko J. Martynchyk A.V. Titorenko I.B. №4(24) 2016
Manifestations of early anthracycline cardiotoxicity in patients with breast cancer receiving combination chemotherapyAuthors: Askоlskiy А.В. Sivak L.A. Zharinov O.I. Antomonov M.Y.... №4(24) 2016
Treatment of HIV-related
non-Hodgkin’s lymphomas in the era of highly active antiretroviral therapyAuthors: Kryachok I. Skripets Т.V. Ulianchenko K.O. Titorenko I.B.... №3(23) 2016
Prognostic and predictive value
of the biological markers in locally advanced breast cancerAuthors: Sivak L.A. Verevkina N. Lyalkin S. Mаydаnеvich N.... №4(20) 2015
Granulocyte colony stimulating factor use during anticancer therapyAuthors: Kryachok I. Titorenko I.B. №3(19) 2015
Results of a multicenter randomized study on the efficacy and toxicity of therapy in patients with Hodgkin’s lymphoma of intermediate-risk groupAuthors: Amdiyev A.A. Kryachok I. Titorenko I.B. Kadnikova T.... №3(19) 2015
Long-term results of treatment of lung cancer patients with paraneoplastic rheumatic syndromeAuthor:Lysenko1 S.A. №1(17) 2015
Diagnosis and treatment of lymphoma during pregnancyAuthors: Novosad I.O. Pastushenko J. Skripets Т.V. Kryachok I. №4(16) 2014
The digest of scientific-research workshop for oncologists «Prophylaxis and treatment of chemotherapy complications (hematological toxicity)»Authors: Gubareva G.O. Filonenko K.S. Aleksik О.М. №4(16) 2014
Neoadjuvant chemotherapy in the treatment of patients wiht malignant tumors of oral cavity, oropharinx and hypopharynx III, IVА and IVВ STAGEAuthors: Vorobyov O.N. Shmikova E.V. Vorobyov N.О. №3(15) 2014
Modern approaches to the treatment of esophageal cancerAuthors: Kondratskyi Y. Kirkilevskyi S.I. Zаitsev S.L. Krahmalyov P.S.... №3(15) 2014
Erlotinib (Tarceva) as first-line treatment for patients with non-small cell lung cancer with EGFR mutations: analysis of effectiveness
